Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 6, 2007-11 ,pp. : 594-611

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 5, 2004-09 ,pp. : 449-455

Bentham Science Publishers

Access to resources Recommend Favorite

Crosstalk of oncogenic and prostanoid signaling pathways

By Müller Rolf  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 8, 2004-08 ,pp. : 429-444

Springer Publishing Company

Access to resources Recommend Favorite

Pro-apoptotic activity of oncogenic H-Ras for histone deacetylase inhibitor to induce apoptosis of human cancer HT29 cells

By Choudhary Shambhunath   Wang Hwa-Chain  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 10, 2007-10 ,pp. : 725-739

Springer Publishing Company

Access to resources Recommend Favorite

The Potential Value of Immunohistochemistry as a Screening Tool for Oncogenic Targets of Personalized Lung Cancer Therapy

By Ilie Marius   Hofman Paul  

The Journal of OncoPathology, Vol. 1, Iss. 1, 2013-04 ,pp. : 82-92

Optimal Clinical Ltd

Access to resources Recommend Favorite